Canada: Dolly Varden Reasons Deliver Highly Anticipated Guidance For Assessing Tactical Private Placements Under The New Take-Over Bid Regime

The Ontario Securities Commission (OSC) and the British Columbia Securities Commission (BCSC) have released joint reasons for their decisions in the Dolly Varden dispute. As expected, these reasons provide capital markets participants with guidance (including a framework) for assessing the future use of private placements as a defensive tactic (i.e. so-called "tactical" private placements) under Canada's new harmonized take-over bid regime (New Bid Regime) that came into effect on May 9, 2016.

For more information about the New Bid Regime, see our previous article, Canada's New Take-Over Bid Rules Seek to Level the Playing Field.

What is a Tactical Private Placement?

A tactical private placement occurs when a target company issues securities in response to an unsolicited take-over bid in order to make it more difficult and/or more expensive for the hostile bidder to complete a take-over of the target company. This outcome is particularly important to target companies under the New Bid Regime for two key reasons. First, as a consequence of the New Bid Regime, shareholders rights plans (i.e. poison pills) are largely irrelevant in deterring hostile bids because such offers must remain open for at least 105 days (rather than 35 days under the old rules). Second, the New Bid Regime contains a mandatory condition that a minimum of more than 50% of all outstanding target securities owned or held by persons other than the bidder and its joint actors be tendered and not withdrawn before the bidder can take up any securities under the take-over bid (the Minimum Tender Condition). The Minimum Tender Condition cannot be waived by a bidder.

The Dolly Varden Dispute

The Dolly Varden dispute is noteworthy because it's the first time since the adoption of the New Bid Regime that Canadian securities regulators have considered whether a contemplated private placement is an inappropriate defensive tactic.

The basic facts of the Dolly Varden dispute are as follows:

Hecla Mining Company, made an all-cash offer for all of the outstanding common shares of Dolly Varden Silver Corporation.

Hecla first announced its intention to proceed with the offer on June 27 and formally commenced the offer on July 8.

A few days later, Dolly Varden communicated to its shareholders that they should take no action with respect to the hostile bid, and that Dolly Varden would be proceeding with a private placement it had previously announced on July 5.

Hecla's offer was subject to a number of conditions, including that the private placement announced on July 5 would be abandoned by Dolly Varden.

On July 8 and July 12, Hecla filed applications with the BCSC and the OSC respectively, seeking to cease trade the private placement on the basis that it was an abusive defensive tactic in contravention of Canadian securities laws. At the time of these applications, Dolly Varden had not received approval from the stock exchange for the private placement, nor had the private placement closed. As such, Dolly Varden agreed not to close the private placement until Hecla's applications had been resolved.

On July 25, the commissions released their decisions dismissing Hecla's application, thus allowing Dolly Varden to proceed with the private placement.

In their joint reasons, the commissions explained that they had determined that the private placement had been instituted for non-defensive business purposes because: (i) Dolly Varden was contemplating an equity financing considerably in advance of Hecla's announcement of the offer (and therefore it was not implemented for the tactical purpose of circumventing the bid); (ii) the private placement had not been modified in response to the bid so as to become defensive in character; (iii) the size of the private placement and the decision to proceed with the private placement was reasonable in light of Dolly Varden's liabilities and planned activities (including the fact that Dolly Varden needed cash); and (iv) given the history between the parties, Hecla could reasonably have expected that Dolly Varden would seek to raise money through an equity financing.

Guidance for Assessing Tactical Private Placements

General

The joint reasons provide capital markets participants with important guidance on the future use of private placements as a defensive tactic under the New Bid Regime, including the following considerations:

  1. private placements may serve multiple corporate objectives and, as such, are more challenging for securities regulators to review than cases involving poison pills, especially with respect to determining whether the corporate objective of the private placement was only to alter the dynamics of a bid environment;
  2. when reviewing the appropriateness of a private placement in the take-over bid context, securities regulators need to balance the extent to which the private placement serves bona fide corporate objectives, for which corporate law gives significant deference to a board of directors in exercising its business judgement, with the securities law principles of facilitating shareholder choice with regard to corporate control transactions and promoting open and even-handed bid environments; and
  3. a private placement should only be blocked by securities regulators where there is a clear abuse of the target shareholders and/or the capital markets.

Conducting the Analysis

The joint reasons also outline the following framework for conducting the analysis of a private placement in the take-over bid context:

Is the private placement clearly not a defensive tactic?

The starting point is to consider whether the evidence clearly establishes that the private placement is not, in fact, a defensive tactic designed, in whole or in part, to alter the dynamics of the bid process.

In terms of the evidentiary burden, where a bidder is able to establish that the impact of a private placement on an existing bid environment is material, then the target board has the onus of establishing that the private placement was not used as a defensive tactic.

In determining whether the private placement is clearly not a defensive tactic, the following non-exhaustive list of considerations is relevant.

  • whether the target has a serious and immediate need for financing;
  • whether there is clear evidence of a bona fide, non-defensive, business strategy adopted by the target; and
  • whether the private placement has been planned or modified in response to, or in anticipation of, a bid.

Should the securities regulators intervene?

If a transaction fails the first branch of the test, and is or may be a defensive tactic, the analysis does not stop there. The securities regulators will still need to determine whether or not it is appropriate to intervene.

In determining whether to intervene in a tactical private placement, the following non-exhaustive list of considerations is relevant:

  • whether the private placement would otherwise benefit the target company's shareholders;
  • the extent to which the private placement alters the pre-existing bid dynamics;
  • whether the investors in the private placement are related parties to the target or whether there is some evidence that some or all of them will act in such a way as to enable the target's board to "just say no" to the bid or a competing bid;
  • whether there is any information available about the views of the target company's shareholders with respect to the take-over bid and/or the private placement; and
  • where a bid is underway as the private placement is being implemented, whether the target's board appropriately considered the interplay between the private placement and the bid, including the effect of the resulting dilution on the bid and the need for financing.

Of course even where these considerations are not engaged, regulators retain broad jurisdiction to intervene to protect the capital markets.

Until Next Time...

Remedies

The fact that Dolly Varden had agreed with the commissions not to close the private placement until Hecla's application had been resolved, taken together with the fact that the commissions decided against Hecla, was critical to the analysis. This fact left open (presumably, for another day...) a full discussion of what remedies might be available to a successful applicant in the context of a private placement that's already closed.

On the subject of remedies, the commissions did make two importance observations.

The first is that, once completed, unwinding a completed financing transaction will involve potentially difficult issues denying the target and its shareholders and the investors in the private placement of the benefits of the contractual commitments that have been made.

The second is that, if the private placement has the effect of preventing a bidder from satisfying the Minimum Tender Condition, a bidder could potentially seek relief from securities regulators to exclude the shares issued in a private placement, for the purpose of determining whether the Minimum Tender Condition has been satisfied. Given the objective of most bids is to acquire 100% ownership of a target company, this remedy will likely only be satisfactory to a bidder where it could still reasonably acquire enough securities in order to be able to complete a second step takeout transaction for the minority position post-bid.

Forum

The other issue that didn't get addressed in the joint reasons is the issue of forum. That is, when is it appropriate for securities regulators, as opposed to stock exchanges or courts to consider the appropriateness of a private placement in the take-over bid context? In the Dolly Varden dispute, the courts were not involved, and the stock exchange had not yet approved the private placement at the time of the hearings, and so the issue of forum did not arise.

Issues concerning forum are related to remedies given different remedies are available in different forums.

Conclusion

While any private placement will need to be examined in light of its own unique factual background, the joint reasons of the OSC and the BCSC in the Dolly Varden dispute provide capital markets participants with guidance (including a framework) for assessing the future use of tactical private placements under the New Bid Regime. The guidance and framework provided appears to be a culmination of the decisions of the securities regulators that pre-date the New Bid Regime, together with careful consideration of defensive tactics policies in light of the changes imposed by the New Bid Regime.

To view original article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.